Insider Shareholders with Direct Ownership of A Ikido Pharma Inc. (AIKI)
This section provides a comprehensive overview of the insiders with direct ownership of A Ikido Pharma Inc. (AIKI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
AIkido Pharma Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Kyle Michael Wool
President |
1,324,176 | 0 | 1,912,585 $7.27 Million | 27 |
Dec 31, 2024
Added 13.91%
|
|
Soo Yu
Director |
611,939 | 0 | 820,478 $3.12 Million | 4 |
Jun 21, 2023
Added 39.23%
|
|
Anthony Hayes
CEO |
711,395 | 0 | 686,823 $2.61 Million | 24 |
Dec 31, 2024
Added 31.04%
|
|
George Way
Chief Financial Officer |
96,311 | 0 | 96,311 $365,981 | 1 |
Oct 02, 2023
Added 50.0%
|
| 16,198 | 0 | 30,033 $114,125 | 5 |
Dec 26, 2023
Added 18.9%
|
|
|
Tim S Ledwick
Director |
33,000 | 0 | 12,826 $48,738 | 2 |
Aug 26, 2022
Added 38.41%
|
|
Robert J Vander Zanden
Director |
33,000 | 0 | 12,702 $48,267 | 2 |
Aug 26, 2022
Added 38.64%
|
|
Gregory James Blattner
Director |
33,000 | 0 | 12,411 $47,161 | 2 |
Aug 26, 2022
Added 39.19%
|
|
Paul Le Mire
Director |
33,000 | 0 | 12,411 $47,161 | 2 |
Aug 26, 2022
Added 39.19%
|
|
Robert Frederick Dudley
Director |
33,000 | 0 | 12,411 $47,161 | 2 |
Aug 26, 2022
Added 39.19%
|